Cart
Free Shipping in the UK
Proud to be B-Corp

Advances in Clinical Chemistry Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)

Advances in Clinical Chemistry By Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)

Summary

Explores the biochemistry of bilirubin, the end-product of heme metabolism with respect to its potential beneficial role in preventing oxidative changes associated with a variety of pathological conditions including atherosclerosis, cancer, inflammatory, autoimmune and other degenerative diseases.

Advances in Clinical Chemistry Summary

Advances in Clinical Chemistry: Volume 43 by Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)

Volume 43 of the Advances in Clinical Chemistry series contains review articles of wide interest to clinical laboratory scientists and diagnostic adventurers. In this volume, the biochemistry of bilirubin, the end-product of heme metabolism, is explored with respect to its potential beneficial role in preventing oxidative changes associated with a variety of pathological conditions, including atherosclerosis, cancer, and inflammatory, autoimmune and other degenerative diseases.

About Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)

Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.

Table of Contents

The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress-Mediated Diseases Cyclooxygenase-2 and Tumor Biology Oligonucleotide Probes for RNA-Targeted Fluorescence In Situ Hybridization Activin A In Brain Injury Methods for Predicting Human Drug Metabolism A Summary Analysis of Down Syndrome Markers in the Late First Trimester Estrogen Hydroxylation in Osteoporosis Cytochrome P450: Another Player in the Myocardial Infarction Game? Index

Additional information

NPB9780123737038
9780123737038
0123737036
Advances in Clinical Chemistry: Volume 43 by Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)
New
Hardback
Elsevier Science Publishing Co Inc
2007-02-06
304
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Advances in Clinical Chemistry